The trademark application ATLAS translational PhD program was filed by TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant") and BioNTech SE, a corporation established under the laws of the Federal Republic of Germany (the "Co-Applicant", and jointly with the "Applicant" referred to as the "Applicants" going forward). The application was published for oppositions on November 23, 2022, and it was registered by office on March 2, 2023 without any oppositions.
The application was filed in German (English was selected as the second language).